Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Erik Ostrowski Insider Profile
4 Followers
Erik Ostrowski, Interim CEO, President and CFO at Tectonic Therapeutic, holds 350.00K shares in Akebia Therapeutics (Ticker: AKBA), holds 29.29K shares in Tectonic Therapeutic (Ticker: TECX).
Erik Ostrowski has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Erik Ostrowski holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Erik Ostrowski
Erik Ostrowski's Trading History
Tectonic Therapeutic
Feb 05, 2024
Interim CEO, President and CFO
Uninformative Buy
34.27K
$481.45K
Akebia Therapeutics
Jul 02, 2024
SVP, CFO, CBO & Treasurer
Uninformative Buy
―
$511.00K
List of latest transactions for each holding click on a transaction to see Erik Ostrowski's performance on stock
You May Also Like
Erik Ostrowski insider profile FAQ
What is the percentage of profitable transactions made by Erik Ostrowski?
The percentage of profitable transactions made by Erik Ostrowski is ―.
What is the average return per transaction made by Erik Ostrowski?
The average return per transaction made by Erik Ostrowski is ―.
What stocks does Erik Ostrowski hold?
Erik Ostrowski holds: TECX, AKBA stocks.
What was Erik Ostrowski’s latest transaction?
Erik Ostrowski latest transaction was an Uninformative Buy of ―.
What was Erik Ostrowski's most profitable transaction?
Erik Ostrowski’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Erik Ostrowski's role in Tectonic Therapeutic?
Erik Ostrowski's role in Tectonic Therapeutic is Interim CEO, President and CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.